Clinical Trial Update: A Phase I/II Study of Cediranib (AZD2171) in Japanese Metastatic Colorectal Cancer Patients in Combination With FOLFOX [Phase 1, Phase 2]

View source ↗

Summary

Phase I/II study evaluating Cediranib (AZD2171) in combination with FOLFOX for Japanese patients with metastatic colorectal cancer. The trial is completed with …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Cediranib (AZD2171) (cediranib)
• FOLFOX regimen (folinic acid (leucovorin) + fluorouracil + oxaliplatin)

Snippet

Sponsor: AstraZeneca | Conditions: Metastatic Colorectal Cancer | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2012-06-05